Sarepta up 8%, Piper sees 60% upside  Seeking Alpha

Sarepta Therapeutics (SRPT +7.6%) is up on below-average volume. Piper Jaffray, citing the upcoming data readout in Limb-girdle muscular dystrophy, has …

X